Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ChromoTek Changes Distribution in the USA and Canada

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
ChromoTek has changed its partner to Bulldog Bio Inc.

ChromoTek GmbH has changed its partner in the USA and Canada to Bulldog Bio Inc for its entire line of affinity reagents.

Bulldog Bio will now handle all sales and support of their extensive line of novel tools for protein and cell biology.

Chromotek’s nanobody-based reagents have opened the door to enhancing research with GFP and RFP fusion proteins, chromatin, cell cycle, and epigenetics analyses.

Bulldog Bio will focus its marketing effort to build a North American business with equal penetration as seen in the European market.

“Chromotek’s nanobody-based GFP-Trap, RFP-Trap, GFP-Booster and RFP-Booster affinity reagents have already been referenced more than 400 times in peer-reviewed publications. This is a testament as to the power of Chromotek’s products to make solid contributions to labs who utilize GFP- and RFP-fusion proteins in their research.”, Ella Fontaine further details “It is our goal, not only to provide the existing customers with better prices and faster service, but also spread the message that these reagents can help your research goals immediately.”

The terms of the distribution contract have not been disclosed.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nippon Genetics and Bulldog Bio Create Alliance in North America
Bulldog Bio to sell many of Nippon Genetics’ electrophoresis and cell biology products.
Thursday, July 18, 2013
Eppendorf Licenses Thermal Cycler Technology to Bulldog Bio
License covers the GenePro and LifePro gradient thermal cycler models sold by Bulldog Bio.
Wednesday, September 07, 2011
Acqua Science Signs Bulldog Bio as Exclusive Partner in the USA
Partnership allows Bulldog Bio to exclusively represent Acqua Science’s new line of protein analytical tools.
Wednesday, June 29, 2011
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!